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DOI: 10.1039/c1sm05024aThe remarkable mechanical characteristics of the spider silk protein major ampullate spidroin protein
suggest this polymer as a promising biomaterial to consider for the fabrication of scaffolds for bone
regeneration. Herein, a new functionalized spider silk-bone sialoprotein fusion protein was designed,
cloned, expressed, purified and the osteogenic activity studied. Bone sialoprotein (BSP) is a multi-
domain protein with the ability to induce cell attachment and differentiation and the deposition of
calcium phosphates (CaP). Attenuated Total Reflection Fourier Transform Infrared (ATR-FTIR) was
used to assess the secondary structure of the fusion protein. In vitro mineralization studies
demonstrated that this new fusion protein with BSP retained the ability to induce the deposition of
CaP. Studies in vitro indicated that human mesenchymal stem cells had significant improvement
towards osteogenic outcomes when cultivated in the presence of the new fusion protein vs. silk alone.
The present work demonstrates the potential of this new fusion protein for future applications in bone
regeneration.1. Introduction
The increasing demand for organs and tissues to replace
damaged or diseased systems represents a major health challenge
worldwide. Bone grafting is the second most frequent transplant
procedure after blood transfusion. Transplantation of bone
tissue from autogeneic and allogeneic sources has been a major
strategy in tissue repair. However, major challenges regarding
transplantation remain, including the limited availability of
suitable and safe tissues and organs, frequent adverse immune
responses and disease transmission, loss of biological and
mechanical properties after processing, high costs and worldwide
scarcity.1 As an option, tissue engineering has been explored for
bone regeneration with the objective of generating bone func-
tional equivalents to overcome the limitations of the currently
used methodologies mentioned above.2 For this purpose
different polymers with diverse mechanical and biological char-
acteristics have been studied with respect to support for regen-
eration of damaged bone tissue.3–5a3B’s Research Group—Biomaterials, Biodegradables and Biomimetics,
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4964 | Soft Matter, 2011, 7, 4964–4973Silk proteins, derived from spiders and silkworms, are partic-
ularly relevant polymers for consideration as biomaterial scaf-
folds for bone regeneration. Silks harbour remarkable
mechanical properties, while also offering slow biodegradation in
vivo and appropriate biological compatibility.6 While silkworm
silk has been extensively studied with regard to bone tissue
formation in vitro and in vivo, spider silks have been less studied
in this context.
Spiders produce different types of silk for different functions.
Among these different silk types, the major ampullate silk, or
dragline silk, secreted by the major ampullate gland presents
tensile strength comparable to Kevlar (4  109 N m2) and
extensibility around 35%, compared to 5% for Kevlar.7 Major
ampullate silk protein has a molecular structure comprising
b-sheet forming crystalline regions that alternate with less
organized regions. These two regions correspond to two chemi-
cally distinct blocks in the protein polymer chains, where the
hydrophilic GGX motifs (G stands for glycine and X is mostly
glutamine) are responsible for the less crystalline regions and the
poly-alanine (poly-A) motifs form the crystalline regions. The
hydrophobic poly-A motifs are responsible for the formation of
rigid and highly packed anti-parallel b-sheets8 due to hydrogen
bonding, generating the physical cross-links that stabilize silk
structures in these crystalline regions. The GGX motif adopts
a helical conformation forming amorphous regions that connect
the poly-A motifs providing elasticity to the silk fibers.9 The
combination of glycine-rich domains with the poly-A regions and
the formation of b-sheet cross-links between blocks give rise to
the impressive mechanical properties of major ampullate silk
fibers.10
The silk from the silkworm Bombyx mori can be supplied in
large scale by sericulture, however, no equivalent productionThis journal is ª The Royal Society of Chemistry 2011
Fig. 1 SDS-PAGE gels for 6mer and 6mer + BSP proteins, stained with
colloidal blue.
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View Onlineprocess is currently available for spider silks. For this reason the
production of spider silk is carried out in heterologous expres-
sion systems, such as Escherichia coli, as used by us and other
research groups to provide sufficient spider silk for study.10,11
Furthermore, the use of recombinant DNA technology in the
synthesis of these protein-based biopolymers has significant
advantages over conventional production systems, allowing
precise control of the protein primary sequence and thus its
chemistry, and control of block distribution.11 The major
ampullate spidroin protein (MaSpI), produced by the spider
speciesNephila clavipes, is one of the spider silks most extensively
studied using recombinant DNA technology.7 Compared with
Bombyx mori silk spider silk is stronger and has no immunogenic
coat of sericin as in the case of B. mori silk.12 Furthermore, the
high strength, toughness and light weight properties of spider
silk, along with expression in heterologous systems make MaSpI
a suitable choice for the fabrication of high performance
biomaterials for bone regeneration applications.
An advantage of using genetically engineered fibrous proteins
such as spider silks is the possibility of generating new genetic
variants carrying new functional domains. Therefore the
synthesis of new chimeric proteins with enhanced features when
compared with the native isolated counterparts can offer
multifunctional features that otherwise are difficult to obtain,
require extensive chemical modifications or are challenging to
control during preparation. Thus, MaSpI can be expressed
together with other proteins resulting in new chimeric proteins,
retaining the self-assembly and outstanding mechanical perfor-
mance of the native silk materials, but adding new functional
features to improve or control biocompatibility and osseointe-
gration. We have previously demonstrated this approach with
both silica13 and hydroxyapatite14 nucleation domains fused to
spider silk.
The ability of bone sialoprotein (BSP) to induce the attach-
ment and migration of endothelial cells,15 together with adhesion
and differentiation of osteoblasts16 related to bone remodelling
has been demonstrated.17 The ability to induce cell adhesion is
related to the presence of a C-terminal RGD sequence in BSP
that binds to integrins.18–22 Additionally, in vivo studies indicate
that incorporation of BSP into collagen23,24 or titanium25
implants promoted osteoblast differentiation and proliferation
and enhanced osteoinductive effects. Furthermore, BSP is also
responsible for the deposition of calcium phosphate in bone
tissues, especially after association with collagen type I.26 There is
some evidence that in the early stages of mineralization
hydroxyapatite crystals nucleate and grow inside the 68 nm gaps
(hole zones) present between the triple-helical collagen fibrils.
The labelling of BSP allowed the detection of the protein in these
hole zones between the collagen fibrils suggesting that this
protein may regulate the onset of calcification.27 Additionally,
different studies address the ability of BSP protein to interact
with different binding partners28 including collagen,26 hydroxy-
apatite,29 matrix metalloproteinase, factor H,30 and integrin avb3
present in cell membranes18,19
The objective of the present study was the generation of a new
silk fusion protein through the combination of BSP and MaSp1
consensus sequences. The silk block carries six repeats of the
consensus repeat unit for the native sequence of the major
ampullate dragline silk I from N. clavipes. Each silk repeat isThis journal is ª The Royal Society of Chemistry 2011formed by a hydrophilic GGX motif and a hydrophobic poly-A
motif.
The present work describes the assembly of a new molecular-
level biomaterial combining a spider silk consensus sequence
with the complete sequence for BSP. When compared with
previous silk chimeras13,14 this new fusion protein has the
advantage of combining the remarkable mechanical performance
and self-assembly capability of silk with the multi-domain BSP
sequence. This multi-domain BSP is advantageous for the
concurrent control of the different processes related to osteo-
genesis described above.2. Results and discussion
The presence of the BSP insert in the cloning vector containing
the silk modules was confirmed through DNA sequencing. SDS-
PAGE indicated that both expression and purification of the
6mer + BSP and the silk control, only 6mer, were successful and
protein sequencing confirmed the N-terminal amino acid
sequence. The purity level for both proteins was around 95% for
6mer and 90% for 6mer + BSP. For 6mer + BSP protein the
theoretical molecular weight is approximately 52 kDa and with
SDS-PAGE it was possible to observe a strong band at around
49 kDa. In the case of the 6mer the estimated molecular weight is
approximately 21.8 kDa and the SDS-PAGE showed a band at
28 kDa (Fig. 1). This discrepancy between the expected and
observed molecular weight in the case of 6mer protein has been
reported previously for other silk proteins.31–33 During SDS-
PAGE the migration rate of proteins can be affected not only by
its size but also by the protein shape.34 The tendency of silk
proteins to aggregate can be a possible cause for their slow
migration during electrophoresis. After purification, dialysis and
lyophilization the yields of 6mer + BSP and 6mer were approx-
imately 17 mg L1 and 25 mg L1, respectively.
The expressed 6mer + BSP and 6mer proteins were used to
cast 2% protein films that were self-supporting after dehydration
and methanol treatment. ATR-FTIR analysis to the 6mer + BSP
protein films demonstrated that the introduction of the BSP
domain with the spider silk did not disrupt the self-assembly
capacity of the silk sequence, manifested through the formationSoft Matter, 2011, 7, 4964–4973 | 4965
Fig. 2 (A) ATR-FTIR spectra of the 6mer and 6mer + BSP films after 2
hours treatment with 70% methanol. (B) Percentage of b-sheet and
random coil/helix conformations after ATR-FTIR spectra deconvolution
of the 6mer and 6mer + BSP films.
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View Onlineof b-sheet after treatment with methanol (Fig. 2). The ATR-
FTIR spectra of 6mer and 6mer + BSP films after 2 hours
treatment with 70% methanol solution exhibited strong amide I
(1700–1600 cm1) and amide II (1600–1500 cm1) regions
(Fig. 2A). ATR-FTIR spectra for both protein films, 6mer + BSP
and 6mer, exhibited vibrational modes in the range of 1650–1647
cm1 amide I region, indicative of helix/random coil conforma-
tions and in the range of 1626–1628 cm1, amide I region, and at
1533 cm1, amide II region, both peaks indicative of antiparallel
b-sheet structures.35–37 After spectral deconvolution the
percentage of helix/random coil and antiparallel b-sheet struc-
tures was determined (Fig. 2B). For both protein films the
percentage of secondary structures was similar and statistical
analysis indicated no significant differences (p > 0.05) betweenFig. 3 (A) Surface morphologies and (B) EDS characterization of the 6mer a
hours.
4966 | Soft Matter, 2011, 7, 4964–4973the 6mer + BSP and 6mer control films. For helix/random coil
conformations the percentages were 35% for the 6mer films and
37% for the 6mer + BSP films. For b-sheet structures the
percentages were 33% and 32% for the 6mer and 6mer + BSP
films, respectively.
Furthermore, this new protein retained the function of BSP to
induce the nucleation of calcium phosphate (CaP), confirmed by
energy dispersive spectroscopy (EDS) and field-emission scan-
ning electron microscopy (SEM). After 1 hour in accelerated
calcification solution (ACS) at 37 C SEM analysis did not
generate evidence for the formation of minerals on either film,
6mer or 6mer + BSP (Fig. 3A). However, EDS analysis indicated
the presence of calcium (Ca) and phosphorus (P) in the 6mer +
BSP films but not in the 6mer films (Fig. 3B). The Ca/P ratios in
6mer + BSP films varied between 1.72 and 1.86. After 6 hours of
incubation it was possible to observe by SEM the formation of
mineral aggregates on the surface of the 6mer + BSP films, with
diameters around 8–10 mm (Fig. 3A). EDS analysis indicated
a composition for Ca and P with Ca/P ratios between 1.82 and
2.03 (Fig. 3B). At longer timescales mineral deposition continues
(data not shown). These results indicate the ability of the 6mer +
BSP sequence to induce the nucleation of CaP, due to the pres-
ence of the BSP domain, a sequence known to be involved in the
mineralization process in bone tissue.27,29 For the 6mer films, the
formation of mineral was not observed even after 6 hours
(Fig. 3A). These results are in agreement with the EDS analysis,
where no mineral was detected on the 6mer control films surface
after 6 hours of immersion in ACS (Fig. 3B).
After 3 days in osteogenic culture media no mineral formation
was observed on the surface of the 6mer + BSP films (Fig. 4),
although EDS characterization confirmed the presence of Ca on
the surface (Fig. 5). Ca/P ratios were 0 after 3 days of culture fornd 6mer + BSP films before and after soaking in ACS solution for 1 and 6
This journal is ª The Royal Society of Chemistry 2011
Fig. 4 Morphology of the 6mer and 6mer + BSP films seeded with hMSCs and cultured for 3, 7 and 14 days. In all assays, the 6mer and 6mer + BSP
films without cells were used as controls. White arrows mark cells with osteoblast-like morphology.
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View Online6mer and 6mer + BSP films and for the controls with no cells,
therefore these values were excluded from Fig. 5.
EDS characterization of 6mer + BSP samples after 7 and 14
days of cell culture in osteogenic culture medium indicated an
significant increase (p ¼ 0.005) in Ca/P ratios from 0.90–1.19 at
day 7 to values between 1.53 and 1.72 at day 14 (Fig. 5). These
last values are very close to those found for tricalcium phosphate
(1.50) and hydroxyapatite (1.67), respectively.38 For 6mer
samples there was also a slight increase in the Ca/P ratio between
day 7 and day 14, from 0.58–0.90 to 0.64–0.93, respectively,
however with no statistical significance. Additionally, statistical
comparison indicated that the Ca/P ratio in 6mer films after 14
days of culture was significantly lower (p ¼ 0.003) than the Ca/P
ratio in 6mer + BSP films (Fig. 5).
EDS analyses for the controls, 6mer + BSP and 6mer films
incubated in osteogenic medium without cells, indicated the
precipitation of CaP in both types of films after 7 and 14 days of
culture. In the case of 6mer + BSP controls the calcium content is
around 1.9 and 1.7 (ESI†) after 3 and 7 days of incubation in
osteogenic medium, respectively, with Ca/P ratios as high as 7.16
after 7 days. In the case of 6mer controls the calcium content is
around 0.3 after 3 and 7 days (ESI†). A possible explanation for
this can be the affinity of the BSP domain in the 6mer + BSP
protein to bind calcium ions. When the time of culture is
increased to 14 days this effect is superimposed by the continuous
precipitation of calcium and phosphate and the Ca/P ratios for
6mer + BSP and 6mer controls reach similar values. Further-
more, for 6mer films without cells, after 7 days of culture, the Ca/This journal is ª The Royal Society of Chemistry 2011P ratio was significantly higher than the ratio registered for these
samples when incubated in the presence of cells. This fact was
also noted for the 6mer + BSP films without cells that registered,
after 7 days of culture, Ca/P ratios between 0 and 7.16 versus 0.89
and 1.18 for 6mer + BSP films with cells. However, statistical
analysis showed no significant difference between both condi-
tions. After 14 days of culture, Ca/P ratios reached values
between 1.26 and 2.07 for 6mer + BSP films without cells, versus
1.53–1.72 obtained for 6mer + BSP films with cells (Fig. 5). This
extended range of Ca/P ratios for 6mer + BSP controls leads to
higher standard deviations when compared with 6mer + BSP
films with cells (Fig. 5) and could be caused by uncontrolled
mineralization processes taking place in 6mer + BSP controls
without cells.
SEM characterization provided an assessment of the
morphology of the CaP formed on the films after cell culture. The
morphologies of the minerals were different, mainly in the case of
the 6mer + BSP films after cell culture vs. 6mer + BSP films
incubated with no cells (control) (Fig. 4). At day 14 the CaP films
formed on 6mer + BSP films presented a globular cauliflower-
like morphology while for the control samples, 6mer + BSP films
without cells, a flat layer of CaP was observed (Fig. 4). Both the
SEM and EDS results suggest that these differences in mineral
morphology and in Ca/P deposition may be the result from the
presence of cells that might play a role in the deposition and
modulation of calcium phosphates, inducing a more controlled
mineralization process. SEM characterization also found
that the human mesenchymal stem cells (hMSC) cultivated onSoft Matter, 2011, 7, 4964–4973 | 4967
Fig. 5 Ca/P ratios determined by EDS after 7 and 14 days of culture
with cells, 6mer and 6mer + BSP, and without cells, 6mer and 6mer + BSP
controls. The values in each bar correspond to the average Ca/P ratio.
Asterisks indicate statistically significant differences (p < 0.05).
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View Online6mer + BSP films during the 3, 7 and 14 days of culture in
osteogenic differentiation medium had osteoblastic-like
morphology, based on their flattened and polygonal morphology
with multiple filopodia or very thin extensions39 (Fig. 4). Cell
viability/proliferation was measured after 3, 7 and 14 days of
culture in osteogenic medium using the Alamar Blue assay.
Results indicated that hMSCs cultured on 6mer + BSP films
supported higher cell viability/proliferation (p < 0.05) than cells
cultured on 6mer films (Fig. 6).
The presence of cell binding domains in the 6mer + BSP
protein within the BSP sequence,15,16 may be responsible for the
cell response when compared with control samples. Several
studies describe the incorporation of RGD sequences to enhance
cell responses to biomaterials.40,41 The coupling of the RGD
triplet to different silk matrices significantly increased the adhe-
sion and proliferation of different cell types such as bone marrow
stromal cells,42 human corneal fibroblasts43 and osteoblasts like
cells (Saos-2). Also, in some studies transcript levels of collagen
I42 and osteocalcin44 increased significantly when Saos-2 andFig. 6 Viability of cells seeded on the 6mer and 6mer + BSP films for 3, 7
and 14 days of culture and determined by Alamar Blue. Cell viability is
expressed in relative fluorescence units. Asterisks indicate statistically
significant differences (p < 0.05).
4968 | Soft Matter, 2011, 7, 4964–4973human corneal fibroblasts were cultivated in silk matrices func-
tionalized with RGD. Furthermore, calcification was also
significantly elevated in the presence of RGD sequences.44 So, in
the present study the presence of the RGD triplet in the BSP
sequence of 6mer + BSP protein enhanced cell responses which
can potentiate the production of mineralized extracellular
matrix. However this effect can overlap with the potential of the
BSP epitopes to induce CaP nucleation.
For the 6mer films, osteoblast-like morphology was not as
evident and a reduction in viability/proliferation was observed
after 3, 7 and 14 days in osteogenic medium.
Quantitative real time reverse transcription-polymerase chain
reaction (quantitative real time RT-PCR) was used to assess the
expression of alkaline phosphatase (ALP), integrin bone sialo-
protein (IBSP), collagen type I a 1 (COL1A1) and collagen type
II a 1 (COL2A1). The expression of bone-related genes by
hMSCs cultured on 6mer + BSP indicated significant (p < 0.05)
up-regulation of ALP, IBSP and COL1A1 during 14 days of cell
culture (Fig. 7). For the 6mer samples a significant decrease (p <
0.05) in the expression level was observed for ALP, COL1A1
from day 3 to day 14, and the expression of IBSP gene was low at
days 3 and 7 and increased at day 14 (Fig.7).
ALP transcript levels for both 6mer + BSP and 6mer films were
similar for days 3 and 7, while day 14 transcript levels were
significantly (p < 0.05) higher on the 6mer + BSP samples. ALP is
considered an osteoblast marker45 and an increase in the level of
ALP transcripts suggests ordered deposition of mineral phase
within the extracellular matrix.46 Alkaline phosphatase is
responsible for the release of orthophosphates through the
cleavage of polyphosphates or pyrophosphates47,48 which func-
tion as inhibitors of apatite formation.49 Humans and mice
lacking ALP exhibit a decrease in bone biomineralization.48 This
function for ALP suggests possible reasons why ALP is impor-
tant in the mineralization process. In the present study, the
difference in ALP responses may suggest one reason for the
differences in mineralization that were observed with the SEM
and EDS data.
With the onset of mineralization other genes are expressed.46
This is the case for IBSP expression, usually confined to later
stages of osteoblast differentiation and early stages of mineral
deposition.38 The IBSP gene codes for BSP, a protein synthesized
mostly in bone tissue and involved in mineralization, constituting
approximately 15% of the non-collagen matrix in young bone.50
Furthermore, BSP is capable of binding to calcium ions and
hydroxyapatite and inducing cell and collagen attachment
through its cell binding and collagen binding domains, respec-
tively. For the 6mer + BSP samples, a significant up-regulation of
IBSP transcript from day 3 to day 7 of cell culture (Fig. 7) was
observed. This result is in good agreement with the results for
ALP gene expression, suggesting active mineralization in 6mer +
BSP films.
IBSP up-regulation also reflects the induction of synthesis of
other extracellular proteins,41 such as collagen type I. Type I
collagen is the most abundant extracellular matrix protein in
bone tissue and is involved in early stages of the mineralization,
as described earlier.51,52 Type I collagen also functions as a scaf-
fold where non-collagenous proteins bind to act as mineral
nucleators. In this way, collagen I fibers play an important role in
bone formation as both a primary building block and for higherThis journal is ª The Royal Society of Chemistry 2011
Fig. 7 Transcript levels from hMSCs cultured on the 6mer and 6mer +
BSP films after 3, 7 and 14 days for genes COL1A1, ALP and IBSP.
Asterisks indicate statistically significant differences (p < 0.05).
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View Onlineorganized architectures related to this process.38 The transcript
data indicate significant up-regulation of COL1A1 for the 6mer
+ BSP samples, indicating a progressive increase of type I
collagen.
In the 6mer + BSP samples, the up-regulation of COL1A1
transcripts accompanied the increase in ALP and IBSP
expression levels after 3, 7 and 14 days in culture. For the 6mer
samples, COL1A1 transcripts were significantly (p < 0.05)
down-regulated between day 3 and day 14, although transcript
levels were higher when compared with the 6mer + BSP samples
at 3 and 7 days of cell culture. After 14 days down-regulation of
COL1A1 was lower than for the 6mer + BSP samples. This
significant decrease in the expression levels of COL1A1 between
day 3 and day 14 of culture for 6mer samples could be due toThis journal is ª The Royal Society of Chemistry 2011a reduction in the metabolic activity of cells due to a reduction
in cell viability as shown in Fig. 6. Also for 6mer samples the
significant decrease in ALP expression levels between day 7 and
day 14 and the late increase in IBSP transcripts, when compared
with 6mer + BSP samples, can be indicative of a low osteogenic
potential of 6mer films. Finally, the absence of COL2A1 tran-
script (data not shown), a marker for chondrogenic differenti-
ation, confirmed that no chondrogenic differentiation was
taking place in the 6mer + BSP or in the control 6mer samples.
During culture with or without cells the protein films main-
tained their integrity.
Quantitative real time RT-PCR for ALP, IBSP and COL1A1
suggested that controlled mineralization was occurring on the
6mer + BSP films during culture in osteogenic medium when
compared with the control 6mer films. These findings concur
with the Ca/P ratios determined by EDS characterization, which
increased from day 3 to 14 of culture, with an increase from 0 to
1.53–1.72, values similar to tricalcium phosphate (1.50) and
hydroxyapatite (1.67), respectively.38 The in vitro results sug-
gested that the cells were actively involved in the mineralization
process. Osteoblasts are the main cells responsible for the oste-
ogenic process, involved in the deposition of bone organic matrix
and in mineralization. This extracellular matrix is formed by
collagen, non-collagen proteins (BSP, osteopontin, osteocalcin)
and polysaccharides.38 Osteoblasts also secrete alkaline phos-
phatase, an enzyme responsible for the hydrolysis of pyrophos-
phate, a known inhibitor of mineralization, into orthophosphate
for incorporation along with calcium ions into the growing
mineral lattice.47,48,53 The osteogenic potential of the hMSCs used
in the present study was confirmed by the deposition of a calcified
matrix, based on both SEM and EDS analyses, as well as the
real-time RT-PCR data.
Over the past decades several protein systems were described
for different applications such as the development of new
protein-based materials for biomedical applications.54 Addi-
tionally, the design of new hybrid proteins, such as the ones
described in the present work, may provide a new generation of
high performance structures for bone regeneration applications.
Recently, the recombinant spider silk protein 4RepCT was used
to fabricate films, foams and fibers and in vitro cell viability tests
showed that these mesh matrices were capable of sustained cell
culture.55 Other studies described the development of fibers
through the electrospinning of recombinant spider silk MaSpI56
and ADF-357 analogues, stable hydrogels fabricated from
recombinant ADF-4 dragline protein with superior mechanical
properties58 and microcapsules of recombinant ADF-4 protein
with high mechanical stability and suitable for drug delivery.59
These studies highlight the versatility of silk proteins to be pro-
cessed into different types of matrices according to the specific
application. Furthermore, the functionalization of these silk-
based materials with biologically active domains is an important
strategy to influence tissue and cell responses, as is the case of the
new 6mer + BSP protein described in the present study. In this
study 6mer and 6mer + BSP protein films were used in the
different tests. However, since this work is considered a first step
towards the development of high-performance protein-based
materials, other processing approaches will be used in future
work for the design of more complex structures for future tissue
engineering and biomedical purposes.Soft Matter, 2011, 7, 4964–4973 | 4969
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View Online3. Experimental
Cloning of BSP into pET30L vector containing the silk modules
The vector pET30a+ (Novagen, San Diego CA) was used for the
construction of the vector pET30L carrying the silk block
copolymer and its assembly was described in our prior studies.35
The spider silk block copolymer was cloned together with six
histidine residues to facilitate purification.35The clone containing
the bacterial plasmid pENTR223.1 carrying the human BSP
cDNA sequence (Clone Identification: HsCD00082642) was
purchased from the Harvard clone collection ‘‘The ORFeome
Collaboration’’ (Dana-Farber/Harvard Cancer Center, Boston
MA). The clones with pENTR223.1 plasmid carrying the BSP
cDNA sequence were inoculated in Luria Bertani (LB) medium
and grown overnight at 37 C with shaking (200 rpm min1). The
pENTR223.1 plasmid was extracted using a Qiagen miniprep kit
(28704, Valencia, CA, USA) for plasmid isolation and digested
with SfiI enzyme (R0123S, New England Biolabs, Ipswich, MA,
USA) which cuts in the regions flanking the BSP cDNA
sequence. The digestion product was run in a 0.8% agarose gel
and the band for the BSP cDNA sequence (951 bp) was purified
using a QIAquick gel extraction kit (28706, Qiagen). For ligation
of the BSP cDNA sequence to the 6mer spider silk clone, a linker
was designed containing in its central region a restriction site for
SfiI for insertion of the BSP clone, and also restriction sites for
SpeI (R0133S, New England Biolabs) and NheI (R0131S, New
England Biolabs) related to the spider silk clone. For insertion of
the linker in the expression vector pET30L, the vector was
digested with SpeI, dephosphorylated with Alkaline Phospha-
tase, Calf Intestinal (CIP) enzyme (M0290S, New England
Biolabs) and run on a 0.8% agarose gel. The linearized vector was
purified using the QIAquick gel extraction kit. The linker was
double digested with SpeI and NheI restriction enzymes gener-
ating compatible ends with those generated by SpeI with the
expression vector pET30L. The linker was run on a 0.8% agarose
gel and purified using the QIAquick gel extraction kit. The linker
was then inserted in the linearized vector pET30L. The ligation
reaction was carried out with T4 DNA ligase enzyme (M0202S,
New England Biolabs).
Escherichia coli DH5a cells (18258-012, Invitrogen, Carlsbad,
CA, USA) were transformed with the ligation product and trans-
formantswere identifiedby incubation on agar plates containing 25
mgml1 kanamycin.Thepresenceof the linker in thepET30Lvector
was confirmed by DNA sequencing. For the insertion of the BSP
cDNA sequence both vector pET30L carrying the linker (vector
pET30L + linker) and vector pENTR223.1 alone were digested
with SfiI. In the case of the linearized vector pET30L + linker the
ends generated by the digestion with SfiI were dephosphorylated
with CIP. After running both digestion products in a 0.8% agarose
gel the bands corresponding to the BSP cDNA sequence and to the
linearized vector pET30L + linker were purified using the QIA-
quick gel extraction kit. The ligation reaction between the vector
pET30L+ linker and theBSP cDNAsequencewas carried outwith
T4 DNA ligase. E. coli DH5a cells transformed with the ligation
product were identified by incubation in agar plates containing 25
mg ml1 kanamycin. The presence of the BSP insert was confirmed
byDNAsequencing (TuftsCoreFacility,Boston,MA)andthenew
constructs were named 6mer + BSP.4970 | Soft Matter, 2011, 7, 4964–4973Protein expression, purification and identification
Both 6mer and 6mer + BSP proteins were expressed in E. coli
RY-3041 strain, a mutant strain of E. coli BLR(DE3) defec-
tive in the expression of SlyD protein.60,61 Cells were culti-
vated at 37 C in LB medium, with 25 mg ml1 kanamycin
until an OD600 between 0.9 and 1 was reached. At this point
expression was induced by adding isopropyl b-D-thiogalacto-
side (IPTG, 15529019, Invitrogen) to a final concentration of
0.5 mM. After 2 hours cells were harvested by centrifugation
at 6500 rpm. The cells pellet was resuspended in a denaturat-
ing buffer (100 mM NaH2PO4, 10 mM Tris–HCl, 8 M urea,
pH 8.0) and left overnight with stirring for complete cell lysis.
Insoluble cell fragments and soluble proteins present in the
cell lysate were separated by centrifugation at 11 000 rpm.
The supernatant was mixed with Ni-NTA resin (30250,
Qiagen) and left for 2 hours with stirring. The supernatant/
Ni-NTA resin mixture was loaded onto a glass Econo-column
(Biorad, Hercules, CA, USA) and washed several times with
denaturating buffer at pH 8 and at pH 6.0. The protein
6mer + BSP was eluted using denaturating buffer at pH 4.5.
The purified protein was dialysed first against a 20 mM
sodium acetate buffer followed by extensive dialysis against
water using cellulose ester snake skin membranes with a 100–
500 Da molecular weight cut off (131054, Spectra/Por
Biotech, Rancho Dominguez, CA, USA). Finally, the dialyzed
proteins were lyophilized.
Protein sequencing (Tufts Core Facility, Boston, MA) and
SDS-PAGE were used to confirm the protein identity. For SDS-
PAGE, proteins were mixed with NuPAGE LDS sample buffer
(Invitrogen, NP0007) and heated at 80 C for 10 minutes.
Afterwards, the samples were separated using a bis-tris 4–12% gel
(Invitrogen, NP0321BOX). For band detection was used the
colloidal blue staining kit (Invitrogen, LC6025).
Film formation and secondary structure analysis
Both recombinant 6mer + BSP and 6mer proteins were dissolved
in MQ water to a final concentration of 2% (w/v). Then 60 ml of
each protein solution was cast into a plastic non-adherent
polystyrene surface, for easier film removal, and left to dry at
room temperature. The films were treated with a solution of 70%
methanol in MQ water for 2 hours to induce the transition of
secondary structure from random coil to b-sheet. For cell and
mineralization studies the films were treated with 70% (v/v)
ethanol solution for sterilization purposes.
The transition of the silk secondary structure was confirmed
by ATR-FTIR (Jasco model FT/IR-6200 type A, Easton, MD,
USA). Spectra were collected in absorption mode at 8 cm1
resolution using 64 scans in the spectral range 4000 to
400 cm1. The quantification of secondary structure was based
on the analysis of the amide I region (1700 to 1600 cm1) and
3 replicates were performed for each 6mer and 6mer + BSP
protein group. The average percentage for the secondary
structures, mainly b-sheet content, for the 6mer (control) and
6mer + BSP proteins were calculated through the integration of
the area of each deconvoluted curve followed by the normali-
zation of the obtained value to the total area of the amide I
region.This journal is ª The Royal Society of Chemistry 2011
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View OnlineIn vitro mineralization
To investigate the mineralization potential of the new chimeric
protein 6mer + BSP, a protein solution was prepared as
described previously and 60 ml of this solution was used to
prepare films. The films were treated with methanol as described
above, and a similar procedure was carried out for the control
6mer protein. Both protein films were incubated for 1 and 6
hours at 37 C, with an accelerated calcification solution (ACS)
of 150 mMNa+, 20 mM of HEPES, 3.75 mM Ca2+ and 2.32 mM
PO4
3, pH 7.4.62 At the end of the incubation periods of 1 and 6
hours the films were washed with MQ water and dried at room
temperature.
In vitro hMSCs responses to 6mer and 6mer + BSP films
Human mesenchymal stem cells (hMSC) were aspirated from
bone marrow originated from a young healthy donor obtained
from Lonza (Walkersville, MD, USA). Frozen passage 3 hMSC
stocks were thawed and seeded at 3.0  103 cells cm2 in a 96
wells plate, containing 6mer and 6mer + BSP films, using basal
medium consisting of Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (v/v) fetal bovine serum
(FBS), 1% penicillin–streptomycin (v/v) and 10 ng of basic
fibroblast growth factor (bFGF) at 37 C with 5% CO2 in
a humidified environment. After cells reach 80–90% confluence
culture medium was changed from basal medium to osteogenic
medium consisting of in DMEM supplemented with 10% (v/v)
FBS, 1% antibiotic/antimycotic, 100 nM dexamethasone, 10 mM
b-glycerol phosphate and 0.05 mM ascorbic acid. Samples were
collected after 3, 7 and 14 days of culture. Medium was changed
every two days.
Analytical methods
Cell morphology was accessed through field-emission scanning
electron microscopy (SEM) (NanoSEM, FEI Nova 200).
Samples were fixed with a 2.5% glutaraldehyde solution in
phosphate buffer (PBS) (v/v) and dehydrated in a series of
ethanol–water solutions with increasing ethanol concentration
(v/v): 25%, 30%, 50%, 70%, 80%, 90% and 100%. For SEM
observation the samples were sputter coated with gold–
palladium.
Alamar Blue (Invitrogen, DAL1025) assay was used to
determine cell viability/proliferation after 3, 7 and 14 days of
culture and 5 replicates were performed for 6mer and 6mer +
BSP films for each time period. The Alamar Blue system incor-
porates an oxidation–reduction indicator (redox indicator) that
fluoresces and changes colour as a result of chemical reduction of
growth media due to cell metabolic activity. This redox indicator
was demonstrated to be minimally toxic to cells. Alamar Blue
reagent was added to the growth media in a 1 : 10 dilution ratio
and data were collected using fluorescence at a 530–560 nm
excitation wavelength and 590 nm emission wavelength.63
For quantitative real time reverse transcription-polymerase
chain reaction (real time RT-PCR) the mRNA of cells was
extracted using RNeasy mini kits (Qiagen, 74106) and cDNA
synthesis was performed using a High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, 4368814). For the PCR
reaction the TaqMan Universal PCR Master Mix (AppliedThis journal is ª The Royal Society of Chemistry 2011Biosystems, 4304437) was used, following the procedure
provided by the supplier, and the Taqman Gene Expression
Assay was used to access the expression of the following genes:
COL1A1 (collagen type I alpha 1, Hs00164004_m1), IBSP
(integrin bone sialoprotein, Hs00173720_m1), ALP (alkaline
phosphatase, Hs00758162_m1), GAPDH (Glyceraldehyde 3-
phosphate dehydrogenase, Hs99999905_m1) and COL2A1
(collagen type II alpha 2, Hs01064869_m1). Results were
normalized to GAPDH expression used as a housekeeping
marker. 9 replicates were performed for each gene.
6mer and 6mer + BSP film characterization
Surface morphology of 6mer + BSP and 6mer films before and
after incubation in ACS for different periods of time was char-
acterized using field-emission scanning electron microscopy
(SEM) (NanoSEM, FEI Nova 200). Samples were sputter coated
with gold–palladium for SEM observation. Elemental composi-
tion of the mineral deposited on the surface of the protein films
was characterized by an energy dispersive spectrometer (EDS)
(EDAX- Pegasus X4M) and no coating was used for this anal-
ysis. SEM and EDS characterizations were also used to charac-
terize 6mer + BSP and 6mer films after 3, 7 and 14 days of cell
culture in osteogenic medium to access mineral deposition. 6mer
+ BSP and 6mer films cultured only with osteogenic medium,
with no cells, were used as controls to test for the possible
influence of cells on mineral deposition. For SEM, samples were
sputter coated with gold–palladium and as mentioned before no
coating was used for EDS analysis. At least 3 replicates were used
in each analysis.
Statistical analysis
SPSS 17.0 was used to perform statistical analysis. The Shapiro–
Wilk test was used to test for the normality of the data. To
compare between two sets of data mainly 6mer + BSP vs. 6mer
films (control) two statistical tests were used: two-tailed
nonparametric Mann–Whitney test for non-normal distributed
data and Student t-test to analyse data with normal distributions.
To test for significant differences between three experimental
groups (3, 7 and 14 days) one-way ANOVA with a Bonferroni
post hoc comparison was applied to the data with normal
distribution and nonparametric Kruskal–Wallis test was used for
the data with non-normal distribution. Statistical significance
was defined as p < 0.05.
4. Conclusions
In summary, the successful design of a new chimeric protein
conjugating spider silk with human bone sialoprotein (BSP) is
described. The combination of both silk and BSP domains in
a single protein chain did not interfere with the functions of each
of the domains. This includes the ability of the spider silk to self-
organize into a b-sheet conformation, an important feature
related with its mechanical properties, and the aptitude of BSP to
induce the nucleation of calcium phosphates. During the 14 days
of culture this new chimeric protein sustained hMSC prolifera-
tion and differentiation into the osteogenic lineage. These data
are evident for cells seeded onto the 6mer + BSP, indicating that
the conjugation with the amino acid sequence of human BSPSoft Matter, 2011, 7, 4964–4973 | 4971
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View Onlineimproves cellular function towards the osteoblastic phenotype.
These promising results suggest the potential for this chimeric
protein as a new biomaterial for tissue engineering applications,
especially for the construction of grafts for bone regeneration.
Additionally, these results also highlight the potential of chimeric
proteins as multifunctional biomaterial systems allowing the
control over different types of cellular response such as cell
differentiation, cell migration and cell adhesion, and protein
adsorption, among others. The importance of this approach
relies on the ability to bioengineer nanoscale composite systems
that can be used in the fabrication of new families of biomaterials
capable of self-modification either before, in vitro, or after
implantation, in vivo.Acknowledgements
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